Main container

Predizione del rischio di frattura nei pazienti affetti da metastasi ossee da carcinoma

Title
Predizione del rischio di frattura nei pazienti affetti da metastasi ossee da carcinoma
Code
RISKFRACT
Type
Osservazionale
Start Year
2024
Status
In Corso

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in

Clinical Trial
A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors
Read more
Clinical Trial
Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors
Read more
Content updated
17/06/2024 15:59